Home Cart Sign in  
Chemical Structure| 51938-32-0 Chemical Structure| 51938-32-0

Structure of Schaftoside
CAS No.: 51938-32-0

Chemical Structure| 51938-32-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Schaftoside is a natural product isolated and purified from the herbs of Desmodium styracifolium (Osh.) Merr. with antioxidant and anticancer activities.

Synonyms: Apigenin 6-C-glucoside-8-C-arabinoside

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Schaftoside

CAS No. :51938-32-0
Formula : C26H28O14
M.W : 564.49
SMILES Code : O=C1C=C(C2=CC=C(O)C=C2)OC3=C1C(O)=C([C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)C(O)=C3[C@H]5[C@H](O)[C@@H](O)[C@@H](O)CO5
Synonyms :
Apigenin 6-C-glucoside-8-C-arabinoside
MDL No. :MFCD21333256

Safety of Schaftoside

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Schaftoside

cytoskeleton
pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human liver microsomes 1 µM, 10 µM 1.5 hours To evaluate the metabolic stability of schaftoside in human liver microsomes. Results showed that after 1.5 h incubation, the remaining amounts of schaftoside were 100.25 ± 1.04% (1μM) and 98.36 ± 1.34% (10 μM) of the initial amounts, indicating poor metabolism of schaftoside in human liver microsomes. Front Pharmacol. 2022 Dec 14;13:1073535
Rat liver microsomes 1 µM, 10 µM 1.5 hours To evaluate the metabolic stability of schaftoside in rat liver microsomes. Results showed that after 1.5 h incubation, the remaining amounts of schaftoside were 102.66 ± 2.41% (1μM) and 97.66 ± 3.30% (10 μM) of the initial amounts, indicating poor metabolism of schaftoside in rat liver microsomes. Front Pharmacol. 2022 Dec 14;13:1073535
Vero E6 cells 11.83 ± 3.23 µM (EC50) 24 hours Evaluate the inhibitory effect of Schaftoside on SARS-CoV-2 virus, showing significant antiviral activity Acta Pharm Sin B. 2022 Nov;12(11):4154-4164
Caco-2 cells 10 µM and 100 µM 3 hours and 5 hours Investigate the metabolism of Schaftoside, results showed that Schaftoside underwent poor metabolism, with only hydroxylated/methoxylated C-glycosides observed as metabolites, and no phase II conjugates containing glucuronic acid or sulfates were detectable. Int J Mol Sci. 2021 Jun 18;22(12):6566

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nilaparvata lugens (brown planthopper) 2-3 instar nymphs of BPH Artificial diet 0.05, 0.1, and 0.15 mg/mL Diet renewed daily, duration of 15 days To investigate the effect of Schaftoside on the survival rate of BPH, results showed that Schaftoside significantly inhibited the survival rate of BPH in a dose-dependent manner. Front Plant Sci. 2018 May 29;9:710
Rats Healthy rats Intravenous injection and oral administration 1.2 mg/kg (iv), 50, 100, 200 mg/kg TFDS (po) Single dose To investigate the pharmacokinetics and excretion pathways of schaftoside in rats. Results showed that after intravenous injection, schaftoside was quickly eliminated from blood circulation (t1/2=0.64 h) and extensively excreted into urine (54.59 ± 9.11%) and bile (24.78 ± 3.07%) as unchanged form. After oral administration of TFDS, plasma exposure of schaftoside was dose-proportional. Front Pharmacol. 2022 Dec 14;13:1073535
BALB/c mice LPS-induced acute lung injury model Intragastric administration 10 and 20 mg/kg Single dose, lasting 8 hours Evaluate the anti-inflammatory effect of Schaftoside, showing significant alleviation of lung inflammation and reduction of pro-inflammatory cytokine levels Acta Pharm Sin B. 2022 Nov;12(11):4154-4164
Root-knot nematode (Meloidogyne incognita) Root-knot nematode (Meloidogyne incognita) Aqueous solution 114.66 μg/mL (LC50) 72 hours To evaluate the nematicidal activity of Schaftoside against root-knot nematodes, showing an LC50 value of 114.66 μg/mL. Molecules. 2011 Jun 20;16(6):5079-86

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.77mL

0.35mL

0.18mL

8.86mL

1.77mL

0.89mL

17.72mL

3.54mL

1.77mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories